Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.50 USD
−8.48 M USD
16.69 M USD
11.82 M
About BioStem Technologies, Inc.
Sector
Industry
CEO
Jason Matuszewski
Website
Headquarters
Pompano Beach
Founded
1939
FIGI
BBG000JZMW15
BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. It offers pre-treatment assessment, cell therapies, anti-aging, and wellness compounds. The company was founded by Andrew Smith Van Vurst, Henry W. Van Vurst IV, and Jason Matuszewski on April 29, 1939 and is headquartered in Pompano Beach, FL.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BSEM is 24.98 USD — it has increased by 11.93% in the past 24 hours. Watch BioStem Technologies, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange BioStem Technologies, Inc. stocks are traded under the ticker BSEM.
BSEM stock has risen by 31.76% compared to the previous week, the month change is a 148.39% rise, over the last year BioStem Technologies, Inc. has showed a 743.92% increase.
We've gathered analysts' opinions on BioStem Technologies, Inc. future price: according to them, BSEM price has a max estimate of 24.25 USD and a min estimate of 24.25 USD. Watch BSEM chart and read a more detailed BioStem Technologies, Inc. stock forecast: see what analysts think of BioStem Technologies, Inc. and suggest that you do with its stocks.
BSEM reached its all-time high on May 27, 2009 with the price of 14,700.42 USD, and its all-time low was 0.01 USD and was reached on Dec 3, 2020. View more price dynamics on BSEM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BSEM stock is 22.27% volatile and has beta coefficient of 1.47. Track BioStem Technologies, Inc. stock price on the chart and check out the list of the most volatile stocks — is BioStem Technologies, Inc. there?
Today BioStem Technologies, Inc. has the market capitalization of 403.88 M, it has increased by 8.93% over the last week.
Yes, you can track BioStem Technologies, Inc. financials in yearly and quarterly reports right on TradingView.
BioStem Technologies, Inc. is going to release the next earnings report on Apr 7, 2025. Keep track of upcoming events with our Earnings Calendar.
BSEM earnings for the last quarter are 0.32 USD per share, whereas the estimation was 0.36 USD resulting in a −11.11% surprise. The estimated earnings for the next quarter are 0.38 USD per share. See more details about BioStem Technologies, Inc. earnings.
BioStem Technologies, Inc. revenue for the last quarter amounts to 82.56 M USD, despite the estimated figure of 78.22 M USD. In the next quarter, revenue is expected to reach 82.13 M USD.
BSEM net income for the last quarter is 6.29 M USD, while the quarter before that showed 4.44 M USD of net income which accounts for 41.51% change. Track more BioStem Technologies, Inc. financial stats to get the full picture.
No, BSEM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BioStem Technologies, Inc. EBITDA is 11.38 M USD, and current EBITDA margin is −45.25%. See more stats in BioStem Technologies, Inc. financial statements.
Like other stocks, BSEM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BioStem Technologies, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BioStem Technologies, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BioStem Technologies, Inc. stock shows the buy signal. See more of BioStem Technologies, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.